Pennsylvania-based medical device manufacturer Biocompatibles Inc., a subsidiary of BTG plc, pleaded guilty today to misbranding its embolic device LC Bead and will pay more than $36 million to resolve criminal and civil liability arising out of its illegal conduct, the Justice Department announced today. LC Bead is used to treat liver cancer, among other diseases.
Medical Device Maker Biocompatibles Pleads Guilty to Misbranding and Agrees to Pay 36 Million
About the Author: Christian Roule
Christian works as the Site Administrator and Content Copywriter for The Coding Network. He is a published author and a member of the IT Team.